Morning Briefing
Summaries of health policy coverage from major news organizations
Biotech Firms Work To Weaken Health Law Provision; J & J Faces Oregon Suit Related To 'Phantom Recalls'
These so-called "phantom recalls" - which have gained the attention of some members of Congress - involved the company's plan to buy back defective Motrin pills from store shelves in order to avoid negative publicity.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
